Trial Profile
Liraglutide for perioperative glycaemic control in type 2 diabetic patients undergoing elective surgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jan 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Hyperglycaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Jan 2015 New trial record